Cargando…

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide

Spinocerebellar ataxia type 3 (SCA3) and type 1 (SCA1) are dominantly inherited neurodegenerative disorders that are currently incurable. Both diseases are caused by a CAG-repeat expansion in exon 10 of the Ataxin-3 and exon 8 of the Ataxin-1 gene, respectively, encoding an elongated polyglutamine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kourkouta, Eleni, Weij, Rudie, González-Barriga, Anchel, Mulder, Melissa, Verheul, Ruurd, Bosgra, Sieto, Groenendaal, Bas, Puoliväli, Jukka, Toivanen, Jussi, van Deutekom, Judith C.T., Datson, Nicole A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695277/ https://www.ncbi.nlm.nih.gov/pubmed/31394429 http://dx.doi.org/10.1016/j.omtn.2019.07.004

Ejemplares similares

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
por: van Deutekom, Judith, et al.
Publicado: (2023)

The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
por: Datson, Nicole A., et al.
Publicado: (2017)

Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice
por: Datson, Nicole A., et al.
Publicado: (2020)

Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy
por: Verheul, Ruurd C., et al.
Publicado: (2016)

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
por: Moore, Lauren R., et al.
Publicado: (2017)

Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes
por: Aydin, Gülsah, et al.
Publicado: (2018)

Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study
por: Choubtum, Lulin, et al.
Publicado: (2015)

Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro
por: González-Barriga, Anchel, et al.
Publicado: (2017)

Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model
por: Yavas, Alper, et al.
Publicado: (2020)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021)

Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells
por: Fiszer, Agnieszka, et al.
Publicado: (2016)

Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide
por: Evers, Melvin M., et al.
Publicado: (2011)

Positive Selection of a Pre-Expansion CAG Repeat of the Human SCA2 Gene
por: Yu, Fuli, et al.
Publicado: (2005)

Tuscany SCA in action
por: Laws, Simon
Publicado: (2011)

Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
por: van Putten, Maaike, et al.
Publicado: (2019)

PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
por: Nethisinghe, Suran, et al.
Publicado: (2018)

Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset
por: Wiethoff, Sarah, et al.
Publicado: (2018)

SCA8 CAG/CTG Expansions, a Tale of Two TOXICities: A Unique or Common Case?
por: Merienne, Karine, et al.
Publicado: (2009)

Radiation Qualification of the SCA Controller Preselection
por: Gingrich, D M, et al.
Publicado: (2003)

Understanding SCA (Service Component Architecture)
por: Marino, Jim, et al.
Publicado: (2009)

Understanding SCA (Service Component Architecture)
por: Marino, Jim, et al.
Publicado: (2010)

COVID-19 et SCA ST+
por: Hakim, R., et al.
Publicado: (2020)

MR Imaging of SCA3/MJD
por: Wan, Na, et al.
Publicado: (2020)

Altered dynamics of scaRNA2 and scaRNA9 in response to stress correlates with disrupted nuclear organization
por: Logan, Madelyn K., et al.
Publicado: (2018)

Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population
por: Faruq, Mohammed, et al.
Publicado: (2015)

SCA2 presenting as a focal dystonia
por: Cheng, Nan, et al.
Publicado: (2018)

SCA8 should not be tested in isolation for ataxia
por: Roda, Ricardo H., et al.
Publicado: (2017)

Phenotypic variance in monozygotic twins with SCA3
por: Zhao, Hua, et al.
Publicado: (2020)

Neuroimaging Biomarkers in SCA2 Gene Carriers
por: Mascalchi, Mario, et al.
Publicado: (2020)

Spinocerebellar ataxia type 31 (SCA31)
por: Ishikawa, Kinya
Publicado: (2022)

The roles of NOP56 in cancer and SCA36
por: Zhao, Shimin, et al.
Publicado: (2023)

Differentiation-Associated MicroRNA Alterations in Mouse Heart-Derived Sca-1(+)CD31(−) and Sca-1(+)CD31(+) Cells
por: Wu, Qiong, et al.
Publicado: (2016)

Testing and Radiation Qualification of the SCA Controller Engineering Prototype
por: Gingrich, D M, et al.
Publicado: (2003)

Analyzing biological network parameters with CentiScaPe
por: Scardoni, Giovanni, et al.
Publicado: (2009)

Wavelength and power stability measurements of the Stanford SCA/FEL
por: Van der Geer, B, et al.
Publicado: (1994)

The Role of Interruptions in polyQ in the Pathology of SCA1
por: Menon, Rajesh P., et al.
Publicado: (2013)

The Pathogenic Role of Low Range Repeats in SCA17
por: Shin, Jung Hwan, et al.
Publicado: (2015)

Gene, Stem Cell, and Alternative Therapies for SCA 1
por: Wagner, Jacob L., et al.
Publicado: (2016)

ScaPD: a database for human scaffold proteins
por: Han, Xiaomei, et al.
Publicado: (2017)

Investigation of Lipid Profile and Clinical Manifestations in SCA Children
por: da Guarda, Caroline Conceição, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ps87706t93af984b4h4br1epoi